Dow Up 1.13% Nasdaq Up 1.41%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
6.52 Down 0.21(3.12%) Oct 31, 3:59PM EDT
|After Hours : 6.53 Up 0.01 (0.15%) Oct 31, 7:58PM EDT
Prev Close:6.73
Open:6.96
Bid:6.44 x 500
Ask:6.53 x 1200
1y Target Est:17.75
Beta:3.09
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.32 - 6.98
52wk Range:5.47 - 27.63
Volume:2,972,294
Avg Vol (3m):4,645,040
Market Cap:344.96M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRDown 3.12%344.96M
APNT 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,034.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.87

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback